Question follow-through · 80726
Selective Serotonin Reuptake Inhibitors: Labelling and Packaging
To ask the Secretary of State for Health and Social Care, what discussions he has had with Selective Serotonin Reuptake Inhibitors (SSRIs) manufacturers on the effectiveness of the packaging and labelling of SSRIs in warning patients of (a) the associated
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 10 Oct 2025
- Target answer date
- 14 Oct 2025
- Answer
- 20 Oct 2025 · 10 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Ketamine: Misuse · 30 Oct 2025
- Private Patients: Complaints · 10 Apr 2026
- Pregnancy: Screening · 20 Apr 2026
- Pharmacy · 18 May 2026
- Endometriosis: Health Services · 18 Jun 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
10 Oct 2025
Question tabled
To ask the Secretary of State for Health and Social Care, what discussions he has had with Selective Serotonin Reuptake Inhibitors (SSRIs) manufacturers on the effectiveness of the packaging and labelling of SSRIs in warning patients of (a) the associated
14 Oct 2025
Target answer date
Date supplied by the official written-questions record.
20 Oct 2025
Answer published
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring that selective serotonin reuptake inhibitor (SSRI) packaging and labelling produced by marketing authorisation holders (MAHs) reflects what is known about the safet...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Ketamine: Misuse
30 Oct 2025 · To ask the Secretary of State for Health and Social Care, what estimate the Government has made of the prevalence of ketamine addiction among under 25s; what steps the Government is taking to address ketamine addiction among young people; and what tailore
Private Patients: Complaints
10 Apr 2026 · To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of complaints and accountability processes for NHS patients referred to private healthcare providers.
Pregnancy: Screening
20 Apr 2026 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the consistency and effectiveness of (a) antenatal screening in detecting fetal cardiac conditions and (b) the efficacy of the Fetal anomaly screening pro
Pharmacy
18 May 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that self employed locum pharmacists are paid in a timely manner for services delivered within NHS contracted pharmacies; and whether he plans to intro
Endometriosis: Health Services
18 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that patients with endometriosis are able to access timely NHS surgical treatment, and to reduce the need for patients to seek private care.
Hydrocortisone
18 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support patients affected by the discontinuation of hydrocortisone sodium phosphate 100mg/1ml solution in the UK, including ensuring continued access to appro
Parkinson's Disease: Prescriptions
18 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of current prescription charging policy on people diagnosed with Parkinson’s disease under the age of 60.
Surrogacy
22 Jun 2026 · To ask the Secretary of State for Health and Social Care, what his Department's planned timetable is for publishing a response to the Law Commission’s 2023 report on surrogacy; and what steps it is taking to address concerns about the impact of potential
Respiratory Syncytial Virus: Vaccination
29 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of eligibility criteria for the Respiratory Syncytial Virus vaccination programme for adults with serious underlying respiratory conditions, including pu
Mental Health Services: Hospital Beds
28 Aug 2026 · To ask the Secretary of State for Health and Social Care, what assessment her Department has made of levels of regional variation in access to inpatient mental health beds; and what action is being taken to ensure that patients are not required to travel
Mental Health
28 Aug 2026 · To ask the Secretary of State for Health and Social Care, what steps her Department is taking to increase levels of early identification of mental health needs in schools, colleges, universities and workplaces.
Maternity Services: Standards
28 Aug 2026 · To ask the Secretary of State for Health and Social Care, what steps her Department is taking to improve maternity and neonatal services across England; and if she will set out how those improvements will benefit hospitals serving local residents across t